Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: Results from the Netherlands Cohort Study on diet and cancer

European Journal of Gastroenterology and Hepatology

Volumn 28, Issue 8, 2016, Pages 896-903

  De Kort, Sander ^a,b   Simons, C C J M ^a   Van Den Brandt, Piet A ^a   Goldbohm, R Alexandra ^a,c   Arts, Ilja C W ^a   De Bruine, Adriaan P ^d   Janssen Heijnen, Maryska L G ^a,d   Sanduleanu, Silvia ^b   Masclee, Ad A M ^b   Weijenberg, Matty P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

^d VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

colorectal cancer; diabetes mellitus; prospective cohort; sex; subsite

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; ASCENDING COLON; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; DESCENDING COLON; DIET; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; SELF REPORT; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONSET AGE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; TIME FACTOR;

ADULT; AGE OF ONSET; AGED; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS;

EID: 84964355174     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000626     Document Type: Article

References (39)

1. Van Dam RM, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002; 136: 201-209
2. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67: 253-256
3. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA. Type 2 diabetes and cancer: umbrella review of meta-Analyses of observational studies. BMJ 2015; 350: g7607
4. Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 2012; 12: 159-169
5. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164-179
6. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592-1600
7. Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96: 546-553
8. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999; 91: 620-625
9. Van den Brandt PA, Goldbohm RA, van't Veer P, Volovics A, Hermus RJ, Sturmans F A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol 1989; 43: 285-295
10. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Chapter 1: epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010; 39: 481-497
11. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CP, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005; 14: 133-137
12. Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 2005; 28: 1805-1807
13. Hughes LA, Schouten LJ, Goldbohm RA, van den Brandt PA, Weijenberg MP. Self-reported clothing size as a proxy measure for body size. Epidemiology 2009; 20: 673-676
14. The Dutch National Institute for Public Health and the Environment. NEVO Table: Dutch food composition table 1986-1987; 1986. The Hague, the Netherlands
15. Goldbohm RA, van den Brandt PA, Brants HA, van't Veer P, Al M, Sturmans F, Hermus RJ. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 1994; 48: 253-265
16. Goldbohm RA, van't Veer P, van den Brandt PA, van't Hof MA, Brants HA, Sturmans F, Hermus RJ. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr 1995; 49: 420-429
17. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994; 50: 1064-1072
18. Simons CC, Hughes LA, van Engeland M, Goldbohm RA, van den Brandt PA, Weijenberg MP. Physical activity, occupational sitting time, and colorectal cancer risk in the Netherlands cohort study. Am J Epidemiol 2013; 177: 514-530
19. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-547
20. Weiderpass E, Gridley G, Nyrén O, Ekbom A, Persson I, Adami HO. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst 1997; 89: 660-661
21. Flood A, Strayer L, Schairer C, Schatzkin A. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 2010; 21: 1277-1284
22. Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 2010; 139: 1138-1146
23. He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer 2010; 103: 120-126
24. Stürmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians health study. Cancer Epidemiol Biomarkers Prev 2006; 15: 2391-2397
25. Peeters PJ, Bazelier MT, Leufkens HG, de Vries F, de Bruin ML. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity. Diabetes Care 2015; 38: 495-502
26. Luo W, Cao Y, Liao C, Gao F. Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta-Analysis of 24 cohort studies. Colorectal Dis 2012; 14: 1307-1312
27. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003; 138: 1-9
28. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 2004; 47: 1175-1187
29. Bouchard DR, Langlois MF, Domingue MÈ, Brown C, LeBrun V, Baillargeon JP. Age differences in expectations and readiness regarding lifestyle modifications in individuals at high risk of diabetes. Arch Phys Med Rehabil 2012; 93: 1059-1064
30. Aparicio T, Guilmeau S, Goiot H, Tsocas A, Laigneau JP, Bado A, et al. Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. Gastroenterology 2004; 126: 499-510
31. Malecka-Panas E, Fligiel SE, Jaszewski R, Majumdar AP. Differential responsiveness of proximal and distal colonic mucosa to gastrin. Peptides 1997; 18: 559-565
32. Olivo-Marston SE, Hursting SD, Lavigne J, Perkins SN, Maarouf RS, Yakar S, Harris CC. Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice. Mol Carcinog 2009; 48: 1071-1076
33. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 2012; 150: 1223-1234
34. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004; 127: 1044-1050
35. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009; 52: 1766-1777
36. Ruiter R, Visser LE, van Herk-Sukel MP, Coebergh JW, Haak HR, Geelhoed-Duijvestijn PH, et al. Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study. Diabetes Care 2012; 35: 119-124
37. le Clercq CM, Bouwens MW, Rondagh EJ, Bakker CM, Keulen ET, de Ridder RJ, et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut 2014; 63: 957-963
38. McBean AM, Yu X. The underuse of screening services among elderly women with diabetes. Diabetes Care 2007; 30: 1466-1472
39. Jackson JM, Defor TA, Crain AL, Kerby T, Strayer L, Lewis CE, et al. Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies. J Clin Epidemiol 2013; 66: 349-350